This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
Persistent left superior vena cava Persistent Left Superior Vena Cava
1. History
Persistent left superior vena cava (PLSVC) is an anatomical variant that occurs when the embryonic left anterior cardinal vein does not disappear normally and persists. Normally, this vessel regresses at around 8–10 weeks of gestation, leaving only the left brachiocephalic vein and the ligament of Marshall.
Arantius first described this structure in 1707, and in the early 20th century it was known only from anatomical observation. Its clinical importance emerged with advances in cardiac surgery, pacemaker implantation, and central venous catheter (CVC) insertion. Cases in which PLSVC was discovered incidentally when central venous catheters or pacemaker leads were inserted via an abnormal route (left subclavian vein → PLSVC → coronary sinus → right atrium) increased.
Recently, as it has become known that the presence of PLSVC affects the procedural route when approaching via the coronary sinus during catheter ablation for atrial fibrillation, it has also drawn attention in the field of cardiac electrophysiology. PLSVC is mostly clinically asymptomatic, but correction may be needed in complex congenital heart malformations with coronary sinus dilation.
2. Causes
PLSVC occurs when normal regression does not take place during fetal cardiovascular development.
In normal development, the left anterior cardinal vein gradually regresses at around 8–10 weeks of gestation, and its residual structure, the left brachiocephalic vein, forms and connects left head and neck venous flow to the right superior vena cava. If this regression fails, the left anterior cardinal vein persists, forming the PLSVC.
When a PLSVC forms, blood from the left head and neck veins (left subclavian vein, left internal jugular vein) flows via the left-sided route (PLSVC) into the coronary sinus and returns to the right atrium. Cases are divided into those in which the normal right superior vena cava is present (~80%) and those in which it is absent (~20%).
No specific genetic variant for its cause has been identified, but because it often appears together with complex congenital heart malformations (especially heterotaxy syndrome, polysplenia), abnormalities in genes related to cardiovascular development are presumed to be indirectly involved. It also occurs sporadically.
3. Genetics
PLSVC mostly occurs as an isolated variant, sporadically and without a specific genetic cause.
Association with heterotaxy syndrome (Heterotaxy/Situs ambiguus):
PLSVC is frequently present in patients with left-right asymmetry abnormalities (heterotaxy).
Genes associated with heterotaxy syndrome (ZIC3, CFC1, genes related to the NODAL signaling pathway) may be indirectly involved.
The frequency of PLSVC is particularly high in polysplenia syndrome (polysplenia, left isomerism).
22q11.2 deletion syndrome:
Some reports have suggested an association between 22q11.2 deletion and PLSVC, but a direct causal relationship has not been established.
Isolated PLSVC:
Familial occurrence is rarely reported, but most cases are isolated and sporadic.
No specific single-gene variant has been identified.
When PLSVC exists in isolation, the clinical need for genetic testing is low. However, when complex congenital heart malformations are present, a comprehensive genetic evaluation is performed.
4. General epidemiology
PLSVC is relatively common among congenital vascular variants.
Incidence in the general population: reported as about 0.3–0.5%.
Patients with congenital heart malformations: PLSVC is present in about 2–10%.
Complex congenital heart malformations (heterotaxy syndrome, etc.): co-occurrence frequency is high, up to ~30–50%.
There is no or minimal sex difference. Large-scale data on racial differences are lacking.
Classified according to the presence or absence of an accompanying right superior vena cava:
Right SVC + PLSVC: about 80–90% (bilateral SVC)
PLSVC alone (absent right SVC): about 10–20%
PLSVC is mostly discovered incidentally. The most common scenario is discovery when, during central venous catheter insertion via the left subclavian vein, the catheter enters an abnormal route (→ coronary sinus → right atrium). It is also discovered incidentally during pacemaker lead insertion, preoperative cardiac CT, transthoracic echocardiography, etc.
5. Pathophysiology
The pathophysiology of PLSVC varies according to the anatomical connection.
Left head and neck venous blood returns via the route PLSVC → coronary sinus → right atrium.
The coronary sinus dilates because it continuously receives increased blood flow (dilated coronary sinus). This becomes a diagnostic clue on echocardiography.
Hemodynamically, venous blood returns properly to the right atrium, so it is mostly asymptomatic.
Atypical connection (PLSVC → left atrium, with intracardiac defect):
Rarely, when the PLSVC connects to the left atrium, deoxygenated venous blood enters the systemic circulation, causing cyanosis and paradoxical embolism.
In this case, corrective surgery or interventional closure is needed.
Association with coronary sinus defects:
When PLSVC is accompanied by a coronary sinus defect (unroofed coronary sinus), blood from the PLSVC enters the left atrium, causing a left-to-right shunt and cyanosis.
Studies have also reported that in atrial fibrillation, the PLSVC can be the origin of an ectopic focus.
6. Symptoms
The symptoms of PLSVC vary greatly depending on the type of connection and accompanying malformations.
Typical connection (→ coronary sinus → right atrium):
Mostly asymptomatic. Because it has no significant effect on cardiovascular function, in some cases it is never discovered during life.
Incidental discovery is the most common clinical presentation.
Atypical connection (→ left atrium, with unroofed coronary sinus):
Cyanosis: decreased SpO₂ due to entry of deoxygenated venous blood into the left heart
Paradoxical embolism: entry of venous thrombi into the arterial system through an intracardiac right-to-left shunt. Increased risk of stroke and peripheral arterial embolism
Atrial arrhythmias: atrial fibrillation or rapid arrhythmias due to an ectopic focus in the PLSVC
Symptoms related to accompanying cardiac malformations:
When PLSVC is accompanied by complex congenital heart malformations (heterotaxy syndrome, atrial septal defect, ventricular septal defect, etc.), symptoms due to the underlying malformation appear.
Even without clinical symptoms, identifying the presence of a PLSVC before procedures such as surgery, pacemaker implantation, or catheter ablation is important for procedural planning.
7. Signs
Physical examination findings:
A PLSVC with a typical connection does not by itself show specific physical examination findings. Diagnosis is made mainly on imaging studies.
Echocardiography findings:
Coronary sinus dilation: the most important clue is an abnormally large-appearing coronary sinus on the subcostal four-chamber view of echocardiography. The normal coronary sinus diameter is about 5–10 mm, and PLSVC is suspected if it exceeds this.
Agitated saline contrast echocardiography: PLSVC can be confirmed if bubbles enter the coronary sinus → right atrium after injection in the left upper limb.
Atypical connection (→ left atrium): bubbles appear first in the left atrium.
Chest CT/MRA findings:
Identification of a vascular structure descending in the left upper mediastinum.
Three-dimensional confirmation of the origin and course of the PLSVC and its connection with the coronary sinus.
Incidental discovery on central venous catheterization:
PLSVC is suspected when a catheter inserted via the left subclavian or left internal jugular vein is seen on chest X-ray following an abnormal course (descending along the left mediastinum and then entering the right atrium).
8. Screening
Because PLSVC is mostly asymptomatic, there is no specific screening program. However, it is important to actively check for PLSVC in the following situations:
Evaluation of the coronary sinus when performing echocardiography:
The size of the coronary sinus must be checked on echocardiography for congenital heart malformations or before cardiac surgery.
If coronary sinus dilation is found, agitated saline contrast echocardiography is additionally performed.
Confirmation before procedures:
Check for the presence of a PLSVC before central venous catheter insertion via the left subclavian or left internal jugular vein and before pacemaker/ICD lead insertion.
When a PLSVC is present, leads may mistakenly enter the coronary sinus, so special care is needed.
Before catheter ablation for atrial fibrillation:
When approaching the left pulmonary veins, check the coronary sinus anatomy and the presence of a PLSVC in advance.
When evaluating complex congenital heart malformations:
In patients with complex malformations such as heterotaxy syndrome, systemic venous anatomy is comprehensively evaluated with CT/MRA.
9. Diagnosis
Tests used to diagnose PLSVC:
Echocardiography:
Coronary sinus dilation is the main clue. The PLSVC and its site of connection are confirmed by agitated saline contrast echocardiography (after intravenous injection in the left upper limb).
In isolated PLSVC, other intracardiac structures are normal, and coronary sinus dilation is the main finding.
With an atypical connection (→ left atrium), bubbles appear first in the left atrium.
Cardiovascular CT angiography (CTA) or MRA:
Three-dimensional confirmation of the origin, course, and diameter of the PLSVC and whether it connects to the coronary sinus.
The presence of an accompanying right SVC and of the left innominate vein (left brachiocephalic vein) is also evaluated.
Provides anatomical information essential for planning procedures or surgery.
Venography:
Left subclavian venography can directly confirm the course and connections of the PLSVC.
Can be performed together with interventional procedures.
Chest X-ray:
Increased vascular shadow in the left mediastinum. PLSVC may be suspected on X-ray when a central venous catheter is positioned along an abnormal course.
10. Treatment
The treatment approach for PLSVC is determined by the type of connection and accompanying malformations.
Typical connection (→ coronary sinus → right atrium): no treatment needed
Treatment is not needed because there is no hemodynamic effect.
Used as anatomical information when planning procedures (central venous catheters, pacemaker leads, catheter ablation).
Atypical connection (PLSVC → left atrium, with unroofed coronary sinus): correction needed
Correction is needed when cyanosis or paradoxical embolism occurs.
Surgical correction: coronary sinus roof repair, PLSVC ligation and reconstruction of a left-to-right anastomosis, etc.
Catheter-based intervention: used when insertion of a defect closure device (occluder) is possible.
Treatment of accompanying congenital heart malformations:
Accompanying malformations such as atrial septal defect and ventricular septal defect receive standard treatment for the respective malformation.
In surgery for complex malformations such as the Fontan operation, the anatomy of the PLSVC must be taken into account when planning the venous return route.
Caution during pacemaker/ICD implantation:
When a PLSVC is present, lead insertion via the left-sided route may be difficult, so a right-sided route or special techniques are needed.
11. Prognosis
The prognosis of PLSVC varies according to the type of connection and accompanying malformations.
Isolated PLSVC with typical connection:
Very good prognosis. Normal life is possible without shortened life expectancy.
Precautions: it is important to identify its presence before procedures (central venous catheter, pacemaker, catheter ablation) to prevent complications.
Atypical connection or accompanying unroofed coronary sinus:
There is a risk of cyanosis, paradoxical embolism, and stroke.
The prognosis after corrective surgery is generally good.
Prognosis is determined by the underlying malformation. Rather than directly affecting prognosis, the PLSVC itself becomes a factor that increases the complexity of surgical planning.
Atrial arrhythmias:
When the PLSVC is the origin of an ectopic focus for atrial fibrillation, antiarrhythmic treatment or catheter ablation may be needed. In this case, ablation within the PLSVC is additionally performed.
12. Prevention
There is no way to prevent the occurrence of PLSVC itself. Clinically, preventing complications caused by PLSVC is important.
Prevention of procedure-related complications:
Check for the presence of a PLSVC before procedures such as central venous catheterization, pacemaker lead insertion, and catheter ablation, and if present, establish an appropriate procedural plan.
If the catheter position is abnormal on the X-ray check after left subclavian catheter insertion, suspect PLSVC and perform additional imaging.
Prevention of complications of atypical connections:
When the PLSVC connects to the left atrium, anticoagulation is considered to prevent paradoxical embolism.
In the long term, corrective surgery or interventional defect closure is performed to prevent entry of deoxygenated venous blood into the systemic circulation.
Regular follow-up:
Isolated typical PLSVC does not require special follow-up, but when accompanying cardiac malformations or a coronary sinus defect are present, regular echocardiographic follow-up is recommended.
Genetic counseling: when complex congenital heart malformations are present, family risk is assessed as part of genetic counseling for those malformations.
13. References
Biffi M, et al. Left superior vena cava persistence in patients undergoing cardiac implantable device implantation: a multicenter study. Europace. 2009;11(9):1177-1183. PMID:19620145
Nsah EN, et al. Persistent left superior vena cava in patients with normal and congenitally abnormal hearts. Clin Cardiol. 1991;14(8):678-682. PMID:1831299
Johansson M, et al. Echocardiographic evaluation of the right heart. J Am Soc Echocardiogr. 2010;23(7):685-713. PMID:20620805
Peltier M, et al. Persistent left superior vena cava associated with coronary sinus dilatation on echocardiography. Eur J Echocardiogr. 2006;7(6):508-510. PMID:16443403
Tak T, et al. Persistent left superior vena cava: clinical implications and management. Int J Angiol. 2002;11(3):131-133. DOI:10.1007/BF01616108
Sarodia BD, Stoller JK. Persistent left superior vena cava: case report and literature review. Respir Care. 2000;45(4):411-416. PMID:10771471
Ratliff HL, et al. Left superior vena cava: review of the literature, clinical implications, and relevance to the electrophysiologist. Pacing Clin Electrophysiol. 2006;29(9):1010-1016. PMID:16981658
Campbell M, Deuchar DC. The left-sided superior vena cava. Br Heart J. 1954;16(4):423-439. PMID:13199660
Goyal SK, et al. Persistent left superior vena cava: a case report and review of literature. Cardiovasc Ultrasound. 2008;6:50. PMID:18939983
Albay S, et al. Persistent left superior vena cava detected during routine dissection in anatomy class. Folia Morphol (Warsz). 2006;65(1):68-70. PMID:16783718